OJEMDA™ (tovorafenib), FDA approved for Pediatric Low-Grade Glioma, available at Biologics by McKesson
April 29, 2024- Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease, was selected by Day One Biopharmaceuticals, as a limited…